CARC 56 Active

CO-56: Procedure / Treatment Not Deemed Effective

TL;DR

Provider absorbs the cost. Appeal with objective functional data and peer-reviewed evidence demonstrating treatment effectiveness. Do not bill the patient.

Action
Appeal
Who Pays
Provider
Appeal
Yes
Patient Impact
None
Disclaimer
This content is for informational purposes only and does not constitute professional billing advice. Always verify information against your payer contracts and current coding guidelines. Consult a certified billing specialist for specific claim issues.

What Does CO-56 Mean?

CO 56 is a contractual obligation adjustment where the payer has determined the treatment is not effective. The provider cannot bill the patient and must demonstrate effectiveness through clinical evidence to overturn the denial. This is particularly common in therapy settings where utilization review has determined the patient has plateaued. The appeal must include objective functional assessments and measurable improvement data — subjective provider notes alone are typically insufficient.

CARC 56 is the payer's clinical judgment that the treatment or procedure billed has not demonstrated effectiveness for the patient's specific condition. This differs from CARC 50 (not medically necessary) and CARC 55 (experimental) in an important way: the payer is not saying the treatment lacks evidence or is not needed — they are saying the evidence shows it does not work, or that it has not produced measurable results for this patient.

This denial frequently appears in rehabilitation settings (physical therapy, occupational therapy, speech therapy) where a payer determines that the patient has reached a treatment plateau and continued sessions are no longer producing functional improvement. It also applies to treatments where the payer has reviewed the clinical literature and concluded the procedure is not effective for the specific diagnosis billed. A common scenario is a therapy clinic that has been seeing a patient for several months, and the payer's utilization review determines that objective functional scores are no longer improving.

The group code matters significantly. CO 56 means the provider must absorb the cost or appeal — the key is presenting clinical evidence of effectiveness, including objective functional assessments and measurable improvement data. PR 56 means the patient is responsible, typically because their plan excludes treatments the payer deems ineffective. For either group code, the appeal strategy centers on demonstrating that the treatment has produced or will produce measurable clinical benefit.

Common Causes

Cause Frequency
Payer deems treatment not effective for the condition The payer's clinical review determined that the treatment or procedure does not have sufficient evidence of effectiveness for the specific diagnosis or condition being treated. This differs from CARC 55 (experimental) in that the treatment may be established but considered ineffective for the particular indication. Most Common
Insufficient clinical documentation of effectiveness The submitted documentation does not adequately demonstrate that the treatment has been effective for the patient or is expected to be effective based on clinical evidence. Progress notes may not show measurable improvement. Most Common
Treatment exceeds reasonable duration The payer has determined that the treatment has continued beyond the expected duration for clinical improvement. For example, physical therapy sessions that continue without documented functional improvement may trigger this denial. Common
Missing prior authorization The procedure or treatment required prior authorization to confirm its effectiveness for the patient's specific condition, and authorization was not obtained before the service was rendered. Common
Coding error misrepresents the treatment Incorrect procedure or diagnosis codes were used, causing the payer's system to flag the treatment as ineffective for the reported condition when it may actually be appropriate under different codes. Occasional

How to Resolve

Demonstrate treatment effectiveness through clinical documentation showing measurable patient improvement and peer-reviewed evidence supporting the treatment for the specific condition.

  1. Document measurable improvement Compile standardized outcome measures and functional assessments that demonstrate the patient has improved or is expected to improve with continued treatment. Include baseline and current scores.
  2. Address the payer's criteria Review the payer's specific effectiveness criteria and structure the appeal to address each criterion with supporting evidence.
  3. File appeal with evidence package Submit the appeal with objective improvement data, clinical practice guidelines, and a physician narrative explaining the treatment plan and expected outcomes.

Common RARC Pairings

The RARC code tells you exactly what triggered the CO-56:

RARC Description
N657 This service is not covered per the patient's benefit plan Review the specific benefit exclusion and gather clinical evidence for appeal →
M76 Missing or incomplete/invalid diagnosis or condition Verify diagnosis coding accurately reflects the condition treated →
N386 This decision was based on a Local Coverage Determination (LCD) Review the specific LCD and verify the treatment meets its criteria →

How to Prevent CO-56

General Prevention

Also Filed As

The same CARC 56 may appear with different Group Codes:

Related Denial Codes

Sources

  1. https://www.mdclarity.com/denial-code/56
  2. https://www.codingahead.com/denial-code-56/
  3. https://billingfreedom.com/list-of-common-denial-codes-and-their-reasons/
  4. Codes maintained by X12. Visit x12.org for official definitions.